
Missed Care Conversations for Patients with DLBCL
Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease whose management is complex and requires open communication amongst a multidisciplinary care team. It has a high rate of relapse, with up to 40 percent of patients relapsing within the first two years after primary treatment. Management of a patient with DLBCL begins with prognostic evaluation of the disease and assessing the potential adverse effects of treatments. It should be followed by evaluations of physical, physiological, cognitive, and socio-economic status of the patient. When considering treatment options, the patient…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.